Adicet Bio
ACET
ACET
101 hedge funds and large institutions have $425M invested in Adicet Bio in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
11.98% more ownership
Funds ownership: 82.99% → 94.97% (+12%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
33% less capital invested
Capital invested by funds: $630M → $425M (-$205M)
Holders
101
Holding in Top 10
8
Calls
$2.19M
Puts
$1.11M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$18.7M | |
| 3 | +$15.3M | |
| 4 |
RI
RTW Investments
New York
|
+$14M |
| 5 |
CAC
Cowen and Company
New York
|
+$13.8M |
Top Sellers
| 1 | -$62.3M | |
| 2 | -$5.49M | |
| 3 | -$5.32M | |
| 4 |
TLP
Tri Locum Partners
New York
|
-$4.95M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.99M |